P0655 : Lamivudine prophylaxis prevents hepatitis B reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non-Hodgkin's B cell lymphomaMauro Viganò, Pietro Lampertico, Maria Goldaniga et al.|Journal of Hepatology|2015Cited by 4
Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphomaMauro Viganò, Pietro Lampertico, G. Grossi et al.|Digestive and Liver Disease|2015Cited by 3